Vascular News

  • Home
  • Vascular News

Vascular News Vascular News is the one-stop source for news and views in the vascular and endovascular world. Subscribe for free on www.vascularnews.com/register

Vascular News is the vascular and endovascular specialist's one-stop source for news, views, comment and controversy. Vascular News is an editorially independent newspaper which reflects the voice of vascular specialists.

Humacyte recently announced the presentation of 36-month data assessing the durability of its Symvess acellular tissue-e...
23/02/2026

Humacyte recently announced the presentation of 36-month data assessing the durability of its Symvess acellular tissue-engineered vessel in extremity arterial trauma patients.

Humacyte recently announced the presentation of 36-month data assessing the durability of Symvess in extremity arterial trauma patients.

Ben Li (Toronto, Canada) ponders the current state of artificial intelligence (AI) application in clinical practice, ana...
20/02/2026

Ben Li (Toronto, Canada) ponders the current state of artificial intelligence (AI) application in clinical practice, analysing the obstacles to scaled use.

Ben Li (Toronto, Canada) ponders the current state of AI application in clinical practice, analysing the obstacles to scaled use.

Preliminary three-month results from the first five human implantations of StentIt’s resorbable fibrillated scaffold (RF...
19/02/2026

Preliminary three-month results from the first five human implantations of StentIt’s resorbable fibrillated scaffold (RFS) reveal a technical success rate of 100% and no device- or procedure-related serious adverse events at 30 days in patients with below-the-knee (BTK) chronic limb-threatening ischaemia (CLTI).

Marianne Brodmann (Graz, Austria) shared early findings from the VITAL-IT 1 study as a first-time data release at LINC 2026.

INTERVIEW: Despite original ambitions to become a journalist, the loss of a close relative to pulmonary embolism (PE) sa...
16/02/2026

INTERVIEW: Despite original ambitions to become a journalist, the loss of a close relative to pulmonary embolism (PE) saw Marianne Brodmann (Graz, Austria) redirect her focus towards the medical world. Now the head of the Division of Angiology at the Medical University of Graz, Brodmann talks bioresorbable scaffold technologies, CREST-2, and artificial intelligence ( ) in this interview with Vascular News on her life and career in the vascular field thus far.

Marianne Brodmann talks bioresorbable scaffold technologies, CREST-2, and AI in an interview on her life and career in the vascular field thus far.

Address


Alerts

Be the first to know and let us send you an email when Vascular News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your business to be the top-listed Media Company?

Share